Present and future-looking investor data is collected and curated by LSN’s Investor Research team through ongoing dialogue with 10,000 life science investors from around the world, identifying their investment mandates.
The LSN business development database is the premier life science company database, covering over 100,000 companies around the world, with a particular focus on the bottom third of the market that is missed by traditional data providers.
Redefining Early Stage Investments is an ongoing conference series establishing a global circuit for early stage life sciences companies to source investors, create relationships, and eventually, get funding.
Raising capital is not a one-time event. It must be an ongoing part of your business strategy. The book reveals the expertise required to continually fundraise and bring your ideas to market.
Life Science Nation (LSN) has built a global partnering ecosystem featuring healthcare startups and the capital investors, co-development, and licensing partners who seek them. This partnering ecosystem consists of the LSN Global Partnering Campaign Database, Focus on Cures Accelerator, and the world-renowned Redefining Early-Stage Investments (RESI) partnering events which work closely with LSNs global tech hub network.